GlycoMimetics Earnings History image   This GLYC earnings history page last updated 4/26/2024
GlycoMimetics Earnings History Chart
PeriodEarnings DateGAAP
Q4 20233/27/2024-0.140
Q3 202311/3/2023-0.140
Q2 20238/2/2023-0.130
Q1 20235/3/2023-0.170
Q4 20223/29/2023-0.190
Q3 202211/9/2022-0.160
Q2 20228/3/2022-0.250
Q1 20224/28/2022-0.280
Q4 20213/3/2022-0.330
Q3 202111/2/2021-0.340
Q2 20218/5/2021-0.280
Q1 20215/3/2021-0.280
Q4 20203/2/2021-0.320
Q3 202011/6/2020-0.290
Q2 20207/31/2020-0.320
Q1 20205/1/2020-0.180
Q4 20192/28/2020-0.340
Q3 201911/7/2019-0.310
Q2 20198/1/2019-0.370
Q1 20195/2/2019-0.330
Q4 20183/6/2019-0.32
Q3 201811/2/2018-0.27
Q2 20188/9/2018-0.26
Q1 20185/3/2018-0.33
Q4 20173/6/2018-0.27
Q3 201711/8/2017-0.24
Q2 20178/3/2017-0.3
Q1 20175/8/2017-0.34
Q4 20163/1/2017-0.36
Q3 201611/4/2016-0.34
Q2 20168/4/2016-0.41
Q1 20165/4/2016-0.4
Q4 20152/29/2016-0.47
Q3 201511/12/2015-0.38
Q2 20158/6/20150.51
Q1 20155/5/2015-0.37
Q4 20143/16/2015-0.39
Q3 201410/31/2014-0.35
Q2 20147/31/20140.39
GlycoMimetics Revenue History Chart
PeriodEarnings DateGAAP
Q4 20233/27/20240.01M
Q3 202311/3/2023NA
Q2 20238/2/2023NA
Q1 20235/3/2023NA
Q4 20223/29/2023NA
Q3 202211/9/2022NA
Q2 20228/3/20220.07M
Q1 20224/28/2022NA
Q4 20213/3/20220.02M
Q3 202111/2/20210.09M
Q2 20218/5/2021NA
Q1 20215/3/20210.00B
Q4 20203/2/20210.00B
Q3 202011/6/20200.00B
Q2 20207/31/2020NA
Q1 20205/1/20200.01B
Q4 20192/28/2020NA
Q3 201911/7/2019NA
Q2 20198/1/2019NA
Q1 20195/2/2019NA
Q4 20183/6/2019NA
Q3 201811/2/2018NA
Q2 20188/9/2018NA
Q1 20185/3/2018NA
Q4 20173/6/2018NA
Q3 201711/8/2017NA
Q2 20178/3/2017NA
Q1 20175/8/2017NA
Q4 20163/1/2017NA
Q3 201611/4/201618000
Q2 20168/4/2016NA
Q1 20165/4/2016NA
Q4 20152/29/201635000
Q3 201511/12/2015NA
Q2 20158/6/201520.04M
Q1 20155/5/2015NA
Q4 20143/16/2015NA
Q3 201410/31/2014NA
Q2 20147/31/201415.00M
Quotes delayed 20 minutes

Email EnvelopeFree GLYC Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options

Next Earnings Date Calendar:

Portland Gen Electric (POR): 4/26/2024 5:00 AM
Aon (AON): 4/26/2024 6:00 AM
Centene (CNC): 4/26/2024 6:00 AM
Ball (BALL): 4/26/2024 6:00 AM
US Silica Holdings (SLCA): 4/26/2024 6:00 AM
Avantor (AVTR): 4/26/2024 6:05 AM
Carter's (CRI): 4/26/2024 6:05 AM
Chevron (CVX): 4/26/2024 6:15 AM
Exxon Mobil (XOM): 4/26/2024 6:30 AM
LyondellBasell Industries (LYB): 4/26/2024 6:30 AM

More from the Next Earnings Dates Calendar

Earnings History:

NOV (NOV): 4/25/2024 6:09 PM
SJW Gr (SJW): 4/25/2024 6:00 PM
NorthWestern (NWE): 4/25/2024 6:00 PM
Provident Bancorp (PVBC): 4/25/2024 6:00 PM
First of Long Island (FLIC): 4/25/2024 5:21 PM
Customers Bancorp (CUBI): 4/25/2024 5:20 PM
Minerals Technologies (MTX): 4/25/2024 5:05 PM
Primis Finl (FRST): 4/25/2024 5:00 PM
AptarGroup (ATR): 4/25/2024 5:00 PM
Codorus Valley Bancorp (CVLY): 4/25/2024 After close

More from the Earnings History archive
GlycoMimetics (GLYC) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

GMED Past Earnings
GMTX Past Earnings
GNCA Past Earnings
GNLX Past Earnings
GNPX Past Earnings
GOSS Past Earnings
GOVX Past Earnings
GRAY Past Earnings
GRPH Past Earnings
GRTS Past Earnings
On this page we presented the GLYC earnings and revenue history archive for GlycoMimetics, comparing the historical top line revenue performance quarter by quarter, as well as the GLYC earnings per share history. Any self directed investor doing their due diligence on GLYC (or any other given stock) can benefit from researching all of the GlycoMimetics past earnings and revenue results going backwards in time, and to help you with this GlycoMimetics earnings history research, on this page we presented each quarter's resulting numbers in both table and graphical form for easy comparison. Studying these numbers can help an investor by providing important context with which to think about GLYC's next earnings report. In your continued research on GlycoMimetics we hope you will be sure to check out the further links included for earnings surprises as well as next earnings dates for GLYC. Thanks for visiting, and the next time you need to research GLYC earnings history (or the earnings history of another stock), we hope you'll think of our site as your go-to earnings history research resource of choice.

Recommended: ANCB market cap history, Institutional Holders of GLBL, Top Ten Hedge Funds Holding NEE.

 

GlycoMimetics Earnings History | www.NextEarningsDate.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in NextEarningsDate.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.